Hepatology - European Medical Journal

Continue

Hepatology

Abstracts
EMJ Hepatology 9.1 Feature Image
1 Mins
5th August 2021

Prevalence and Prognostic Value of Cirrhotic Cardiomyopathy as Defined According with the Proposed New Classification

The prevalence and prognostic relevance of cirrhotic cardiomyopathy (CCM), as defined according with the new core criteria proposed in 2019…
EMJ Hepatology 9.1 Feature Image
2 Mins
5th August 2021

Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium

Non-alcoholic fatty liver disease (NAFLD) is becoming the most frequent cause of chronic liver disease worldwide. The stage of fibrosis…
EMJ Hepatology 9.1 Feature Image
2 Mins
5th August 2021

MicroRNA-27a-3p Modulates FoxO1 to Induce Tumour-Like Phenotypes in Bile Ducts
EMJ Hepatology 9.1 Feature Image
3 Mins
5th August 2021

A MET-Agonistic Antibody Mimicking Hepatocyte Growth Factor Accelerates Liver Regeneration and Improves Survival in Mice Undergoing Carbon Tetrachloride Exposure and Partial Hepatectomy

Small-for-size syndrome (SFSS) is defined by prolonged cholestasis, coagulopathy, and ascites within the first week of liver…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
3 Mins
13th October 2020

Diagnostic and Prognostic Role of Presepsin in Patients with Cirrhosis and Bacterial Infection

Bacterial infection (BI) is a common event in the natural history of cirrhosis, often requiring hospitalisation due to hepatic and extra-hepatic organ dysfunction..
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
2 Mins
13th October 2020

Fibrosis-4 Score for Assessment of Liver Fibrosis is Useful in General Practice

Early recognition of liver fibrosis will be a challenge that continues in the coming years and should be performed by general practitioners (GP)…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
2 Mins
13th October 2020

FIB-4 and APRI Scores Revalidation in a Cohort Study of 69,106 Chronic Hepatitis C Patients

Assessment of liver fibrosis is vital for enabling therapeutic decisions and prognostic evaluation of chronic hepatitis…
EMJ Hepatology [Supplement 2] ILC Congress Review 2020
1 Mins
13th October 2020

Progress in Hepatitis C Testing as Part of the Hepatitis C Elimination Programme in Georgia

In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world’s first national HCV Elimination programme…